August 2, 2013

The Senate was expected to take up a bill designed to secure the drug supply chain and establish a list of "do not compound" medications, but left for recess Friday without voting on it.

July 30, 2013

Big data finds another application and another supporter. Sort of.

The full Senate will shortly take up a new track-and-trace bill (S. 959), which would establish a national system for tracking the pedigree and movement of most pharmaceuticals, from point of manufacture and distribution to the dispensing pharmacy and the patient at the end of the supply chain. The goal: to replace the hodge-podge of different state laws with a single, nationwide track-and-trace system capable of capturing the daily flood of drug production, distribution, dispensing and utilization data and channeling it into an accessible tool by which stakeholders and regulators could secure the pharmaceutical supply chain.

July 26, 2013

A new track-and-trace bill that the Senate is expected to consider would institute a nationwide "track-and-trace" system in place of patchwork state laws with the aim of securing the pharmaceutical supply chain.

July 11, 2013

Legislation introduced in the Senate would coordinate efforts at various levels of government and industry to reduce the growing problem of prescription drug abuse.

July 10, 2013

The National Community Pharmacists Association praised Hawaii elected officials for enacting two new laws that, respectively, will give the state’s residents greater choice of where to fill their prescriptions and additional medical privacy protections.

June 24, 2013

A White House trade policy leader has been appointed as U.S. Trade Representative.

June 21, 2013

A bill passed by the New York state legislature will require baby boomers visiting healthcare providers to be offered a hepatitis C screening.

May 21, 2013

The National Association of Chain Drug Stores has announced that, in written statements submitted for U.S. Senate and House of Representatives committee hearings this week, it noted the essential role of community pharmacy in the success of the 10-year-old Medicare Part D prescription drug program and urged program enhancements focused on the quality and affordability of care.



May 16, 2013

The Senate voted overwhelmingly to confirm a former Virginia Health and Human Services secretary as administrator of the Centers for Medicare and Medicaid Services.

May 13, 2013

New Jersey Gov. Chris Christie signed legislation into law that will allow patients using prescription eye drops to get early refills in order to prevent interruptions in therapy.

May 8, 2013

The Council for Responsible Nutrition and the Natural Products Association announced they have met with the entire freshman class of the 113th Congress, including 83 offices in the House of Representatives and 14 offices in the Senate, as part of their educational efforts to ensure that newly elected members of Congress have accurate information about dietary supplements and their role in good health.

May 7, 2013

The U.S. Senate passed the Marketplace Fairness Act, which would enable states to collect sales tax on online transactions, to widespread applause from big-box retail.

April 26, 2013

The Marketplace Fairness Act is one step closer to passing. The Senate voted 63-30 to end debate on the bill, which would compel online retailers to collect state taxes, and will make a final decision on the bill on May 6.

April 4, 2013

A committee of Florida's state Senate has passed a bill that could limit the use of biosimilars in the state.

March 21, 2013

Gov. Bob McDonnell of Virginia has signed into law the first bill that could limit the reach of follow-on biologics, though the bill includes a two-year sunset clause, meaning it will expire in 2015.

March 19, 2013

Last week, I wrote about Medication Therapy Management and a new bill in the House of Representatives to expand the pool of patients who qualify for MTM programs through Medicare. This week, I’m writing about – wait for it – medication therapy management.

Why? Because MTM is important, vitally important, to the future of community pharmacy, and one of the key health and prevention services that will define the profession in the era of health reform and evidence-based health care.

March 14, 2013

Amid a tide of automatic spending cuts resulting from the failure of Congress and the White House to agree on a budget, the generic drug lobby has offered some suggestions to generate savings.

February 28, 2013

The National Community Pharmacists Association applauded the Kentucky Senate for voting to pass S.B. 107, a bill that will provide transparency regarding how pharmacy reimbursements are determined for multiple source generic drugs, and establish an appeals process when a dispute arises over those payment levels.

February 26, 2013

A state Senate committee in Tennessee is looking into the possibility of allowing supermarkets to sell wine, according to published reports.

February 15, 2013

Two Democrats from West Virginia are sponsoring legislation in the House and Senate to combat prescription drug abuse.

November 20, 2012

When considering new, stiffer regulations governing the compounding of medicines in the wake of the meningitis outbreak, tread carefully and don’t throw the baby out with the bathwater.

That’s the message chain pharmacy had for Congress as lawmakers mull new restrictions on drug compounding by pharmacists.

November 13, 2012

Nearly 160 students, faculty and staff from Duquesne University’s Mylan School of Pharmacy recently visited Capitol Hill to promote the role that pharmacists play in providing medication therapy management services, the university announced Tuesday.

November 7, 2012

Americans woke up Wednesday morning to the news that Barack Obama had won a second term as president of the United States. DSN examines what it means for retail pharmacy.

October 22, 2012

A group that lobbies on behalf of independent pharmacies is urging Pennsylvania Gov. Tom Corbett to sign a bill that would allow retail pharmacies to match the reimbursement terms, pricing and conditions that mail-order pharmacies negotiate exclusively with health insurance plans.